Bruker Company Profile (NASDAQ:BRKR)

About Bruker (NASDAQ:BRKR)

Bruker logoBruker Corporation is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions that enable its customers to explore life and materials at microscopic, molecular and cellular levels. The Company's segments include Bruker Scientific Instruments (BSI) and Bruker Energy & Supercon Technologies (BEST). The Company's products address the evolving needs of an array of customers in life science research, pharmaceuticals, biotechnology and applied markets, among others. Within BSI, the Company is organized into three segments: the Bruker BioSpin Group, the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group and the Bruker Nano Group. BEST designs, manufactures and distributes superconducting materials, primarily metallic low temperature superconductors, for use in magnetic resonance imaging, nuclear magnetic resonance, fusion energy research and other applications.

Industry, Sector and Symbol:
  • Sector: Computer and Technology
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Life Sciences Tools & Services
  • Symbol: NASDAQ:BRKR
  • CUSIP: 11679410
  • Web:
  • Market Cap: $4.25 billion
  • Outstanding Shares: 159,768,000
Average Prices:
  • 50 Day Moving Avg: $23.95
  • 200 Day Moving Avg: $23.19
  • 52 Week Range: $19.58 - $27.85
  • Trailing P/E Ratio: 28.317
  • Foreward P/E Ratio: 21.64
  • P/E Growth: 3.560
Sales & Book Value:
  • Annual Revenue: $1.62 billion
  • Price / Sales: 2.63
  • Book Value: $4.54 per share
  • Price / Book: 5.86
  • Annual Dividend: $0.16
  • Dividend Yield: 0.6%
  • EBIDTA: $264.3 million
  • Net Margins: 9.53%
  • Return on Equity: 27.77%
  • Return on Assets: 10.98%
  • Debt-to-Equity Ratio: 0.49%
  • Current Ratio: 2.29%
  • Quick Ratio: 1.42%
  • Average Volume: 662,576 shs.
  • Beta: 0.98
  • Short Ratio: 3.72

Frequently Asked Questions for Bruker (NASDAQ:BRKR)

What is Bruker's stock symbol?

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

How often does Bruker pay dividends? What is the dividend yield for Bruker?

Bruker declared a quarterly dividend on Monday, May 15th. Shareholders of record on Monday, June 5th will be paid a dividend of $0.04 per share on Friday, June 23rd. This represents a $0.16 dividend on an annualized basis and a yield of 0.60%. The ex-dividend date of this dividend is Thursday, June 1st. View Bruker's Dividend History.

How were Bruker's earnings last quarter?

Bruker Co. (NASDAQ:BRKR) released its earnings results on Wednesday, May, 3rd. The company reported $0.19 EPS for the quarter, topping the Zacks' consensus estimate of $0.19 by $0.00. The firm had revenue of $384.90 million for the quarter, compared to analysts' expectations of $372.59 million. Bruker had a net margin of 9.53% and a return on equity of 27.77%. The firm's quarterly revenue was up 2.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.21 earnings per share. View Bruker's Earnings History.

When will Bruker make its next earnings announcement?

Bruker is scheduled to release their next quarterly earnings announcement on Monday, July, 31st 2017. View Earnings Estimates for Bruker.

What guidance has Bruker issued on next quarter's earnings?

Bruker issued an update on its FY17 earnings guidance on Wednesday, May, 3rd. The company provided earnings per share guidance of $1.05-1.09 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.08. The company issued revenue guidance of $1.64-1.67 billion, compared to the consensus revenue estimate of $1.65 billion.

Where is Bruker's stock going? Where will Bruker's stock price be in 2017?

14 brokers have issued 1-year target prices for Bruker's stock. Their predictions range from $20.00 to $29.00. On average, they expect Bruker's share price to reach $25.09 in the next year. View Analyst Ratings for Bruker.

What are analysts saying about Bruker stock?

Here are some recent quotes from research analysts about Bruker stock:

  • 1. Jefferies Group LLC analysts commented, "4Q16 EPS walloped consensus (+9c / +4c operational), while the initial 2017 EPS outlook bracketed consensus. Commentary pointed to further signs of endmarket stability as EU orders turned positive in 4Q (first time all yr). Net-net, BRKR is managing the P&L better than it ever has, and with end-mkts steadily improving, we like the risk/reward & see room for upside. We modestly raise our '17/18 EPS by +1c/+5c (to $1.08/$1.30)." (2/14/2017)
  • 2. Evercore ISI analysts commented, "Bruker continues to execute well across its business, delivering on impressive GM expansion, while continuing OpEx rationalization and stepping up capital allocation. Thus in terms of what management can control they are doing an excellent job and certainly have delivered much of what shareholders demanded several years ago. That being said end markets remain not fully cooperative, and while EU academic has improved it is off of depressed levels. Given this dynamic core growth remains constrained and in a year where the growth comparable is tough due to tax savings the current outlook for EPS upside is mixed. With shares trading north of 20x we contend that visibility back to 3-5% core growth must improve, and we look for further check points from management in the first part of 2017. We think if bookings momentum continues to accelerate over the next few quarters that will be the signal to get incrementally constructive on shares. Therefore we await additional proof points and in the near-term remain on the sidelines." (2/14/2017)
  • 3. According to Zacks Investment Research, "In the last six months, Bruker has underperformed the broader Medical Products industry. However, current-year estimate revision trend remains bullish bringing back our confidence on the stock. On a positive note, Bruker ended the third quarter of 2016 with earnings and revenues both ahead of the Zacks Consensus Estimate. The company's solid cash balance position on the back of improved free cash flow is indicative of strong fundamentals. Also a comparatively better performance delivered by Bruker’s BioSpin group, optics and semiconductor metrology businesses as well as margin recovery observed in Bruker Nano-surfaces business, encourage us. Evidently the cost-reduction action previously adopted by the company in its Nano-surfaces business played its role suitably. However, revenues declined on a year-over-year basis with a formidable decline in organic revenues. The reduced revenue guidance also indicates a gloomy concern ahead." (12/20/2016)
  • 4. Cantor Fitzgerald analysts commented, "CytoSorbents announced that the company has now received a permanent, dedicated, reimbursement procedure code for CytoSorb in Germany." This is positive news." (12/7/2016)

Are investors shorting Bruker?

Bruker saw a increase in short interest in April. As of April 28th, there was short interest totalling 3,087,724 shares, an increase of 4.8% from the April 13th total of 2,947,556 shares. Based on an average trading volume of 606,270 shares, the short-interest ratio is currently 5.1 days.

Who are some of Bruker's key competitors?

Who owns Bruker stock?

Bruker's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (6.16%), FMR LLC (4.47%), Acadian Asset Management LLC (3.40%), BlackRock Inc. (2.89%), OppenheimerFunds Inc. (2.01%) and AQR Capital Management LLC (1.90%). Company insiders that own Bruker stock include Frank H Laukien, Ingen Chris Van, Joerg C Laukien, Richard A Packer, Stephen W Fesik and Wolf-Dieter Emmerich. View Institutional Ownership Trends for Bruker.

Who sold Bruker stock? Who is selling Bruker stock?

Bruker's stock was sold by a variety of institutional investors in the last quarter, including Marshall Wace LLP, Alliancebernstein L.P., AQR Capital Management LLC, Goldman Sachs Group Inc., Morgan Stanley, Janus Capital Management LLC, TIAA CREF Investment Management LLC and Bank of New York Mellon Corp. Company insiders that have sold Bruker stock in the last year include Ingen Chris Van and Joerg C Laukien. View Insider Buying and Selling for Bruker.

Who bought Bruker stock? Who is buying Bruker stock?

Bruker's stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., FMR LLC, MARSHALL WACE ASIA Ltd, Marshall Wace North America L.P., Point72 Asset Management L.P., Eagle Asset Management Inc., Boston Partners and Vanguard Group Inc.. Company insiders that have bought Bruker stock in the last two years include Frank H Laukien and Richard A Packer. View Insider Buying and Selling for Bruker.

How do I buy Bruker stock?

Shares of Bruker can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Bruker stock cost?

One share of Bruker stock can currently be purchased for approximately $26.62.

Analyst Ratings

Consensus Ratings for Bruker (NASDAQ:BRKR) (?)
Ratings Breakdown: 11 Hold Ratings, 3 Buy Ratings
Consensus Rating:Hold (Score: 2.21)
Consensus Price Target: $25.09 (5.74% downside)

Analysts' Ratings History for Bruker (NASDAQ:BRKR)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/15/2017Jefferies Group LLCReiterated RatingBuy$29.00N/AView Rating Details
5/15/2017Deutsche Bank AGBoost Price TargetHold$25.00 -> $27.00N/AView Rating Details
5/4/2017Cowen and CompanyBoost Price TargetMarket Perform$25.00 -> $27.00HighView Rating Details
4/27/2017Cleveland ResearchUpgradeNeutral -> BuyHighView Rating Details
3/27/2017Janney Montgomery ScottDowngradeBuy -> NeutralLowView Rating Details
2/15/2017BTIG ResearchReiterated RatingHoldN/AView Rating Details
2/14/2017Cantor FitzgeraldSet Price TargetBuy$28.00N/AView Rating Details
2/14/2017Barclays PLCBoost Price TargetHold$22.00 -> $24.00N/AView Rating Details
2/14/2017Evercore ISIBoost Price TargetHold$23.50 -> $26.00N/AView Rating Details
12/14/2016JPMorgan Chase & Co.DowngradeOverweight -> Neutral$23.00 -> $20.00N/AView Rating Details
11/10/2016Leerink SwannInitiated CoverageMarket Perform$21.00N/AView Rating Details
8/3/2016Morgan StanleySet Price TargetHold$23.00N/AView Rating Details
8/3/2016Wells Fargo & CoDowngradeOutperform -> Market PerformN/AView Rating Details
8/3/2016MizuhoLower Price TargetNeutral$28.00 -> $23.00N/AView Rating Details
4/5/2016Bank of America CorpDowngradeNeutral -> UnderperformN/AView Rating Details
3/23/2016Goldman Sachs Group IncBoost Price Target$21.00N/AView Rating Details
3/14/2016Stifel NicolausBoost Price TargetBuy$25.00 -> $32.00N/AView Rating Details
1/6/2016Avondale PartnersInitiated CoverageMarket Perform$26.00N/AView Rating Details
10/15/2015Citigroup IncLower Price TargetNeutral$22.00 -> $20.00N/AView Rating Details
8/27/2015Maxim GroupInitiated CoverageHold$22.00N/AView Rating Details
(Data available from 5/23/2015 forward)


Earnings History for Bruker (NASDAQ:BRKR)
Earnings by Quarter for Bruker (NASDAQ:BRKR)
Earnings History by Quarter for Bruker (NASDAQ:BRKR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/3/2017Q1 2017$0.19$0.19$372.59 million$384.90 millionViewN/AView Earnings Details
2/13/2017Q416$0.37$0.46$464.49 million$470.30 millionViewN/AView Earnings Details
11/2/2016Q316$0.20$0.32$394.14 million$393.90 millionViewN/AView Earnings Details
8/2/2016Q216$0.20$0.20$409.57 million$371.70 millionViewN/AView Earnings Details
5/4/2016Q116$0.15$0.21$360.37 million$375.40 millionViewN/AView Earnings Details
2/10/2016Q415$0.27$0.38$469.98 million$478.20 millionViewN/AView Earnings Details
11/4/2015Q315$0.13$0.19$373.65 million$396.10 millionViewN/AView Earnings Details
8/5/2015Q215$0.17$0.19$391.87 million$396.00 millionViewN/AView Earnings Details
5/6/2015Q115$0.10$0.14$369.80 million$353.50 millionViewN/AView Earnings Details
2/19/2015Q414$0.29$0.30$515.50 million$508.00 millionViewN/AView Earnings Details
11/6/2014Q314$0.15$0.14$436.30 million$419.80 millionViewN/AView Earnings Details
8/6/2014Q214$0.19$0.21$457.90 million$457.40 millionViewN/AView Earnings Details
5/7/2014Q114$0.09$0.11$402.04 million$423.70 millionViewN/AView Earnings Details
2/18/2014Q413$0.22$0.31$452.14 million$552.10 millionViewListenView Earnings Details
11/1/2013Q313$0.22$0.20$452.40 million$439.00 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.14$0.18$426.39 million$454.90 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.14$0.08$416.76 million$393.40 millionViewListenView Earnings Details
2/19/2013Q4 2012$0.24$0.28$483.65 million$517.30 millionViewListenView Earnings Details
11/5/2012Q312$0.15$0.28$421.39 million$447.80 millionViewN/AView Earnings Details
7/31/2012$0.12$0.12ViewN/AView Earnings Details
5/1/2012$0.12$0.14ViewN/AView Earnings Details
2/22/2012$0.29$0.31ViewN/AView Earnings Details
10/27/2011$0.22$0.23ViewN/AView Earnings Details
8/3/2011$0.21$0.20ViewN/AView Earnings Details
4/28/2011$0.15$0.14ViewN/AView Earnings Details
2/23/2011$0.27$0.27ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Bruker (NASDAQ:BRKR)
2017 EPS Consensus Estimate: $1.08
2018 EPS Consensus Estimate: $1.27
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.18$0.21$0.19
Q2 20173$0.17$0.21$0.19
Q3 20173$0.26$0.27$0.27
Q4 20173$0.42$0.45$0.43
Q1 20182$0.22$0.29$0.26
Q2 20182$0.26$0.28$0.27
Q3 20182$0.31$0.32$0.32
Q4 20182$0.40$0.45$0.43
(Data provided by Zacks Investment Research)


Current Dividend Information for Bruker (NASDAQ:BRKR)
Next Dividend:6/23/2017
Annual Dividend:$0.16
Dividend Yield:0.60%
Payout Ratio:16.84% (Trailing 12 Months of Earnings)
14.68% (Based on This Year's Estimates)
13.01% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Bruker (NASDAQ:BRKR)

Dividend History by Quarter for Bruker (NASDAQ:BRKR)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Bruker (NASDAQ:BRKR)
Insider Ownership Percentage: 35.80%
Institutional Ownership Percentage: 69.45%
Insider Trades by Quarter for Bruker (NASDAQ:BRKR)
Institutional Ownership by Quarter for Bruker (NASDAQ:BRKR)
Insider Trades by Quarter for Bruker (NASDAQ:BRKR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/19/2017Frank H LaukienCEOBuy3,200$26.13$83,616.00View SEC Filing  
5/18/2017Frank H LaukienCEOBuy73,000$26.22$1,914,060.00View SEC Filing  
5/16/2017Frank H LaukienCEOBuy1,920$25.88$49,689.60View SEC Filing  
3/17/2017Frank H LaukienCEOBuy4,300$23.34$100,362.00View SEC Filing  
3/13/2017Frank H LaukienCEOBuy2,300$23.74$54,602.00View SEC Filing  
12/15/2016Frank H LaukienCEOBuy4,725$21.22$100,264.50View SEC Filing  
12/13/2016Ingen Chris VanDirectorSell20,000$22.29$445,800.00View SEC Filing  
11/25/2016Frank H LaukienCEOBuy2,124$22.90$48,639.60View SEC Filing  
8/10/2016Richard A PackerDirectorBuy10,000$21.97$219,700.00View SEC Filing  
8/5/2016Frank H LaukienCEOBuy4,500$22.17$99,765.00View SEC Filing  
6/14/2016Frank H LaukienCEOBuy4,174$23.95$99,967.30View SEC Filing  
6/6/2016Joerg C LaukienDirectorSell2,000,000$25.65$51,300,000.00View SEC Filing  
5/9/2016Wolf-Dieter EmmerichDirectorSell21,000$27.35$574,350.00View SEC Filing  
6/15/2015Frank H LaukienCEOBuy1,000,000$19.50$19,500,000.00View SEC Filing  
6/11/2015Frank H LaukienCEOBuy5,901$20.31$119,849.31View SEC Filing  
6/11/2015Stephen W FesikDirectorSell15,000$20.48$307,200.00View SEC Filing  
3/17/2015Charles F Wagner JrCFOSell19,000$18.97$360,430.00View SEC Filing  
3/5/2015Richard A PackerDirectorBuy15,000$19.00$285,000.00View SEC Filing  
2/25/2015Frank H LaukienCEOBuy5,271$18.95$99,885.45View SEC Filing  
12/14/2012Frank H LaukienCEOBuy50,000$14.68$734,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Bruker (NASDAQ:BRKR)
Latest Headlines for Bruker (NASDAQ:BRKR)
DateHeadline logoBruker Co. (BRKR) CEO Frank H. Laukien Purchases 3,200 Shares - May 22 at 1:28 PM logoBruker Launches the S8 TIGER™ Series 2 WDXRF System for Elemental Analysis in Industrial and Academic Research and Materials Quality Control - May 22 at 12:28 PM logoBruker Co. (BRKR) CEO Purchases $1,914,060.00 in Stock - May 19 at 4:24 PM logoInsider Buying: Bruker Co. (BRKR) CEO Purchases 1,920 Shares of Stock - May 17 at 1:22 PM logoBruker Co. Announces Quarterly Dividend of $0.04 (BRKR) - May 15 at 5:48 PM logoBruker Co. (BRKR) Receives Consensus Rating of "Hold" from Brokerages - May 12 at 10:41 PM logo$381.18 Million in Sales Expected for Bruker Co. (BRKR) This Quarter - May 12 at 4:50 PM logoBruker Announces New $225 Million Share Repurchase Program and Quarterly Dividend - May 12 at 3:27 PM logoBruker Co. (BRKR) to Post FY2017 Earnings of $1.10 Per Share, Cantor Fitzgerald Forecasts - May 11 at 11:28 AM logoBruker Co. (BRKR) Short Interest Up 4.8% in April - May 11 at 7:12 AM logo Analysts Anticipate Bruker Co. (BRKR) Will Announce Earnings of $0.21 Per Share - May 10 at 8:04 AM logoBruker Acquires Emerging Light Sheet Microscopy Company Luxendo - May 8 at 10:19 AM logoQ3 2017 EPS Estimates for Bruker Co. Lifted by Leerink Swann (BRKR) - May 8 at 9:06 AM logoJefferies Group LLC Reaffirms Buy Rating for Bruker Co. (BRKR) - May 7 at 10:32 AM logoDeutsche Bank AG Reaffirms Hold Rating for Bruker Co. (BRKR) - May 5 at 3:06 PM logoQ2 2017 EPS Estimates for Bruker Co. Lowered by Jefferies Group (BRKR) - May 5 at 9:54 AM logoLeerink Swann Weighs in on Bruker Co.'s Q2 2017 Earnings (BRKR) - May 5 at 9:54 AM logoBruker Co. (BRKR) Stock Rating Reaffirmed by Cowen and Company - May 4 at 11:27 AM logoInvestor Network: Bruker Corporation to Host Earnings Call - May 4 at 10:14 AM logoBruker Reports First Quarter 2017 Financial Results - May 4 at 10:14 AM logoEdited Transcript of BRKR earnings conference call or presentation 3-May-17 8:45pm GMT - May 4 at 10:14 AM logoBruker (BRKR) Q1 Earnings Meet, Revenues Beat Estimates - May 4 at 10:14 AM logoBruker Co. (BRKR) Issues Quarterly Earnings Results, Hits Expectations - May 4 at 1:25 AM logoBruker Co. (BRKR) Releases FY17 Earnings Guidance - May 4 at 1:13 AM logoBruker Co. (BRKR) Announces Earnings Results, Meets Estimates - May 4 at 1:05 AM logoBruker Co. (BRKR) Announces Earnings Results, Meets Estimates - May 4 at 1:05 AM logoBruker Co. (BRKR) Updates FY17 Earnings Guidance - May 3 at 11:04 PM logoBruker meets 1Q profit forecasts - May 3 at 6:28 PM logoBruker Corp. – Value Analysis (NASDAQ:BRKR) : May 1, 2017 - May 2 at 7:27 PM logoBruker (BRKR) Receiving Somewhat Positive Press Coverage, Report Finds - May 2 at 6:10 PM logoBruker Co. (BRKR) Set to Announce Earnings on Wednesday - May 1 at 2:12 PM logoBruker (BRKR) Earning Very Positive Media Coverage, Analysis Finds - April 29 at 8:11 AM logoBruker Corp. breached its 50 day moving average in a Bullish Manner : BRKR-US : April 28, 2017 - April 28 at 5:00 PM logoBruker Corporation to Present at the 42nd Annual Deutsche Bank Health Care Conference - April 27 at 9:29 PM logoBruker Co. (BRKR) Upgraded at Cleveland Research - April 27 at 12:32 PM logoBruker (BRKR) Earning Somewhat Favorable Media Coverage, Study Finds - April 27 at 12:32 AM logoBruker (BRKR) Given Media Impact Score of 0.03 - April 23 at 2:31 PM logoBruker Co. (BRKR) Expected to Announce Quarterly Sales of $371.98 Million - April 21 at 4:26 PM logoBruker introduces new clinical microbiology assays and kits at ECCMID - April 21 at 8:51 AM logoSomewhat Positive News Coverage Somewhat Likely to Impact Bruker (BRKR) Stock Price - April 20 at 5:27 PM logo Analysts Expect Bruker Co. (BRKR) Will Announce Earnings of $0.19 Per Share - April 19 at 8:39 AM logoBruker Announces Date and Time of First Quarter 2017 Earnings Release and Webcast - April 18 at 12:40 PM logoBruker Co. (BRKR) Given Average Recommendation of "Hold" by Analysts - April 18 at 12:53 AM logoBruker (BRKR) Earning Favorable News Coverage, Report Finds - April 15 at 12:33 PM logoBRUKER CORP Files SEC form 8-K, Change in Directors or Principal Officers - March 29 at 9:23 PM logoBruker Co. (BRKR) Downgraded by Janney Montgomery Scott - March 27 at 3:59 PM logoBruker Introduces the AVANCE™ NEO NMR Research Platform at ENC 2017 - March 27 at 12:20 PM logoBruker Introduces Novel NMR Solutions at ENC 2017 - March 27 at 12:20 PM logoBruker Co. (BRKR) Receives Average Recommendation of "Hold" from Brokerages - March 23 at 12:38 PM logoWhy Is Bruker (BRKR) Down 3.1% Since the Last Earnings Report? - March 22 at 3:46 PM


Bruker (BRKR) Chart for Tuesday, May, 23, 2017

This page was last updated on 5/23/2017 by Staff